December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evaxion A/S - American Depositary Share (NQ:EVAX)

3.110 +0.070 (+2.30%)
Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evaxion A/S - American Depositary Share

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Biotech to announce clinical data for the personalized DNA cancer vaccine EVX-02 at the 2023 American Association for Cancer Research Annual Meeting (AACR)
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Biotech Highlights Promising Data From Personalized Cancer Immunotherapy ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 36 companies set new 52-week lows. 
Via Benzinga
News headline image
Evaxion Biotech, Pantherna Reveals Encouraging Data From mRNA-Based Cancer Vaccine ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday! 
Via InvestorPlace
News headline image
Evaxion and Pantherna announce promising preclinical mRNA vaccine data
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion receives FDA fast-track designation for personalized cancer immunotherapy
From Evaxion Biotech
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-01
From Evaxion Biotech
Via GlobeNewswire
News headline image
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket ↗
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to... 
Via Benzinga
News headline image
Evaxion to present a full clinical readout on two personalized cancer immunotherapies in Q2 2023
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion, ExpreS2ion Ink Research Pact For Cytomegalovirus Vaccine Candidate ↗
 
Via Benzinga
News headline image
Evaxion and ExpreS²ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion announces promising results from Phase 1/2a clinical trial of personalized DNA cancer immunotherapy EVX-02
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Announces Third Quarter 2022 Financial Results and Business Update
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion CEO comments on strategic focus
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion welcomes Per Norlén as new CEO.
From Evaxion Biotech
Via GlobeNewswire
News headline image
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
US Stocks Open Higher; Dow Surges 300 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday. 
Via Benzinga
News headline image
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday ↗
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Spero Therapeutics (NASDAQ:SPRO) shares moved upwards by 122.7% to $1.83 during Thursday's pre-market session. The market value of their outstanding shares is at $64.1 million. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement. 
Via InvestorPlace
News headline image
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket ↗
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem... 
Via Benzinga
News headline image
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.